MAPharm OÜ
Active Registry code 14292621
OÜ Tallinn Registered 11 Jul 2017
MAPharm OÜ is a OÜ based in Tallinn, registry code 14292621, status: active. Main activity: Retail sale of pharmaceutical products. According to EMTA, turnover for Q3 2026 was €1 533 795 with 23 employees.
Turnover
1 533 795 €
↑ 28.0% vs Q2 2026
State taxes
98 654 €
↑ 34.9% vs Q2 2026
Labour taxes
88 706 €
↑ 19.3% vs Q2 2026
Employees
23
−2 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 1.5 mn €above 98% of companiesindustry median 23 652 € · companies in the industry: 7 652
- Labour taxes per employee 3 857 €above 94% of companiesindustry median 1 201 € · companies in the industry: 4 663
- Revenue · 2025 4.2 mn €above 98% of companiesindustry median 16 974 € · companies in the industry: 13 500
- Net profit margin · 2025 -6.4 %above 23% of companiesindustry median 1.3 % · companies in the industry: 9 480
Taxes and turnover
- Company
- Industry median
Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 1 533 795 | 98 654 | 88 706 | 23 |
| Q2 2026 | 1 198 341 | 73 112 | 74 325 | 25 |
| Q1 2026 | 1 295 633 | 85 325 | 70 207 | 22 |
| Q4 2025 | 1 190 552 | 84 707 | 72 780 | 22 |
| Q3 2025 | 1 065 564 | 86 537 | 77 224 | 21 |
| Q2 2025 | 1 027 627 | 73 661 | 73 185 | 21 |
| Q1 2025 | 1 414 459 | 141 505 | 69 862 | 21 |
| Q4 2024 | 982 677 | 58 552 | 57 069 | 24 |
| Q3 2024 | 950 524 | 71 389 | 67 186 | 23 |
| Q2 2024 | 1 077 823 | 71 784 | 64 845 | 22 |
| Q1 2024 | 965 666 | 65 067 | 60 871 | 20 |
| Q4 2023 | 1 001 616 | 52 615 | 48 917 | 21 |
| Q3 2023 | 757 059 | 44 840 | 43 568 | 18 |
| Q2 2023 | 745 003 | 45 310 | 41 358 | 14 |
| Q1 2023 | 775 743 | 70 215 | 39 383 | 13 |
| Q4 2022 | 667 205 | 50 876 | 39 229 | 13 |
| Q3 2022 | 646 381 | 53 098 | 44 034 | 14 |
| Q2 2022 | 698 992 | 50 226 | 40 441 | 14 |
| Q1 2022 | 645 441 | 52 243 | 40 169 | 15 |
Labour taxes per employee per month
1 286 €
Turnover per employee in the quarter
66 687 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 4 174 860 | -265 732 | 729 636 | 764 873 | -419 069 | 17 |
| 2024 | 4 017 894 | 41 047 | 679 901 | 1 128 645 | -153 337 | 16 |
| 2023 | 3 166 227 | -126 720 | 507 806 | 797 866 | -194 384 | 19 |
| 2022 | 2 536 605 | 105 216 | 398 199 | 505 893 | -67 664 | 12 |
| 2021 | 2 249 721 | 55 770 | 367 197 | 412 716 | -172 880 | 14 |
| 2020 | 1 913 331 | -54 211 | 342 223 | 392 704 | -228 650 | 11 |
| 2019 | 1 103 019 | -89 373 | 223 412 | 390 186 | -174 439 | 9 |
| 2018 | — | — | — | — | — | 7 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
-6.4 %
Net profit / revenue
Return on assets (ROA)
-34.7 %
Net profit / assets
Equity ratio
-54.8 %
Equity / assets
Debt ratio
154.8 %
Liabilities / assets
Current ratio
0.67
Current assets / current liabilities
Revenue per employee
245 580 €
Revenue / average full-time employees
Labour cost per employee per month
3 577 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 30 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 30 Jun 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 30 Jun 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 30 Jul 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 30 Jun 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 30 Jun 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 31 Oct 2020 | Company’s own | e-Äriregister |
Board
- Marit AasmetsBoard member · since 11 Jul 2017
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Marit AasmetsNatural person · 2 500 €
Beneficial owners
- Marit AasmetsDirect ownership · since 1 Nov 2018
Founders and other persons
- Marit AasmetsFounder · 2 500 € · 10 Jul 2017
Related companies
Activities (EMTAK)
- 47731Retail sale of pharmaceutical products Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50060948 / M4 31 Jul 2025 |
Warning of compulsory dissolution: insufficient net assets | 2 Feb 2026 | Deficiencies eliminated 2 Feb 2026 |
|
| Ä 50060948 / M3 4 Jul 2024 |
Warning of compulsory dissolution: insufficient net assets | 6 Jan 2025 | Deficiencies eliminated 6 Jan 2025 |
|
| Ä 50060948 / 6 2 Sep 2023 |
Amendment entry | In force 2 Sep 2023 |
||
| Ä 50060948 / M2 11 Jul 2022 |
Warning of compulsory dissolution: insufficient net assets | 11 Jan 2023 | Deficiencies eliminated 12 Jan 2023 |
|
| Ä 50060948 / 5 24 May 2019 |
Amendment entry | In force 24 May 2019 |
||
| Ä 50060948 / 4 30 Nov 2018 |
Amendment entry | In force 30 Nov 2018 |
||
| Ä 50060948 / M1 16 Nov 2018 |
Ruling to eliminate deficiencies | 1 Dec 2018 | Deficiencies eliminated 30 Nov 2018 |
|
| Ä 50060948 / 3 19 Jan 2018 |
Amendment entry | In force 19 Jan 2018 |
||
| Ä 50060948 / 2 14 Dec 2017 |
Amendment entry | In force 14 Dec 2017 |
||
| Ä 50060948 11 Jul 2017 |
First entry | In force 11 Jul 2017 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data